Company Profile

Legend Biotech Corporation (NASDAQ: LEGN)
5:00 PM UTC, 07/03/24
Last: $45.91 Change: +1.17 %Change: +2.62% Volume: 356,980
Detailed Quote
Open: $ 44.66   Volume: 356,980
High: $ 46.69   Yield(%) 0.00
Low: $ 44.19   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 8.16B
EPS ($) -2.60   Shares Out: 182.28M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 8.22
% Price Change (last 13 weeks): -20.72
% Price Change (last 26 weeks): -24.30
% Price Change (last 52 weeks): -35.03
% Price Change (year to date): -25.64
Management Effectiveness
Return on Equity (%): -51.94
Return on Assets (%): -32.60
Return on Invested Capital (%): -131.18
Profitability
Gross Profit Margin (%): 42.25
Net Profit Margin (%): -181.75
Operating Profit Margin (%): -155.09
Price & Volume
50-day Moving Average: $43.97
200-day Moving Average: $56.94
Avg. Daily Vol. (last 50 days): 1,184,712
Avg. Daily Vol. (last 200 days): 965,732
52-wk high: $77.32
52-wk low: $38.60
Bid: $44.00
Ask: $46.60
Company Information
Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.
Legend Biotech Corporation
2101 Cottontail Lane
Somerset NJ 08873

Phone: 1.737.317.5050
Fax: n/a
http://www.legendbiotech.com
Per Share Data
Earnings (1year) ($): -2.60
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 6.88
Cash Flow ($): -2.74
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 37.16
Price/Book (x): 8.75
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 6.83
Current Ratio (x): 6.92
LT Debt/Equity (x): 26.01
Total Debt/Equity (x): 26.26



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.